SRLEV revisits tier two issue planned for November to replace acquisition funding
SRLEV, the life insurance arm of SNS Reaal, has revived a tier two issue as it seeks to replace capital borrowed for its acquisition of Swiss Life in 2007.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts